
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
Fin d'année 31 Décembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -66.755 | -52.9 | -53.29 | -31.367 | -41.901 | -32.698 | -13.351 |
Return on Equity (%) | 200.404 | -92.985 | -68.29 | -57.466 | -103.463 | -83.651 | -37.082 |
Return on Invested Capital (%) | -70.29 | -70.094 | -75.157 | -188.26 | -461.286 | -33.688 | -12.295 |
Operating Margin (%) | N/A | N/A | N/A | -346.75 | -163.624 | -79.045 | -21.55 |
Net Profit Margin (%) | N/A | N/A | N/A | -438.855 | -176.047 | -87.681 | -26.104 |
Book Value Per Share | 9.722 | 5.768 | 5.779 | 3.318 | 2.248 | -0.091 | -0.504 |
Earnings Per Share | -3.406 | -2.325 | -3.468 | -2.746 | -3.671 | -3.506 | -1.832 |
Cash Per Share | 10.201 | 0.53 | 4.772 | 1.025 | 0.758 | 6.142 | 4.635 |
Working Capital Per Share | 9.722 | 4.703 | 7.317 | 4.054 | 3.396 | 6.446 | 5.546 |
Operating Profit Per Share | N/A | N/A | N/A | 0.564 | 1.838 | 3.221 | 5.809 |
EBIT Per Share | -3.406 | -2.324 | -3.468 | -2.745 | -3.844 | -3.484 | -1.81 |
EBITDA Per Share | -3.406 | -2.324 | -3.468 | -2.745 | -3.844 | -3.484 | -1.81 |
Free Cash Flow Per Share | -3.406 | -2.319 | -3.471 | -2.144 | -3.751 | -3.307 | -1.887 |
Fin d'année 31 Décembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,09M | 22,6M | 29,78M | 30,58M | 36,96M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 36,81M | 36,96M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -81.293 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -95.354 | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,19B |
Ratio cours/bénéfice | -24,88 |
Ratio prix/ventes | 6,49 |
Ratio prix/liquidités | 9,83 |
Ratio prix/valeur comptable | 9,7 |
Rendement de dividende | - |
Actions en circulation | 49,01M |
Volume moyen (1 semaine) | 657,64k |
Volume moyen (1 mois) | 565,26k |
Variation sur 52 semaines | 57,24% |
Plus haut sur 52 semaines | 54,234 |
Plus bas sur 52 semaines | 23,14 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales